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Summary
Background Immunisation programmes have made substantial contributions to lowering the burden of disease in 
children, but there is a growing need to ensure that programmes are equity-oriented. We aimed to provide a detailed 
update about the state of between-country inequality and within-country economic-related inequality in the delivery 
of three doses of the combined diphtheria, tetanus toxoid, and pertussis-containing vaccine (DTP3), with a special 
focus on inequalities in high-priority countries.
Methods We used data from the latest available Demographic and Health Surveys and Multiple Indicator Cluster Surveys 
done in 51 low-income and middle-income countries. Data for DTP3 coverage were disaggregated by wealth quintile, and 
inequality was calculated as diﬀ erence and ratio measures based on coverage in richest (quintile 5) and poorest (quintile 1) 
household wealth quintiles. Excess change was calculated for 21 countries with data available at two timepoints spanning 
a 10 year period. Further analyses were done for six high-priority countries—ie, those with low national immunisation 
coverage and/or high absolute numbers of unvaccinated children. Signiﬁ cance was determined using 95% CIs.
Findings National DTP3 immunisation coverage across the 51 study countries ranged from 32% in Central African 
Republic to 98% in Jordan. Within countries, the gap in DTP3 immunisation coverage suggested pro-rich inequality, 
with a diﬀ erence of 20 percentage points or more between quintiles 1 and 5 for 20 of 51 countries. In Nigeria, Pakistan, 
Laos, Cameroon, and Central African Republic, the diﬀ erence between quintiles 1 and 5 exceeded 40 percentage 
points. In 15 of 21 study countries, an increase over time in national coverage of DTP3 immunisation was realised 
alongside faster improvements in the poorest quintile than the richest. For example, in Burkina Faso, Cambodia, 
Gabon, Mali, and Nepal, the absolute increase in coverage was at least 2·0 percentage points per year, with faster 
improvement in the poorest quintile. Substantial economic-related inequality in DTP3 immunisation coverage was 
reported in ﬁ ve high-priority study countries (DR Congo, Ethiopia, Indonesia, Nigeria, and Pakistan), but not Uganda.
Interpretation Overall, within-country inequalities in DTP3 immunisation persist, but seem to have narrowed over 
the past 10 years. Monitoring economic-related inequalities in immunisation coverage is warranted to reveal where 
gaps exist and inform appropriate approaches to reach disadvantaged populations.
Funding None.
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Introduction
Vaccines are a safe, eﬀ ective, and cost-eﬃ  cient health 
intervention that have substantially lowered the burden of 
disease in young children and averted many millions of 
deaths. The Expanded Programme on Immunization 
(EPI) was established by WHO in 1974, and since then the 
global health community has shown a serious 
commitment to realising the full potential of vaccines, 
with eﬀ orts dedicated to ensuring widespread vaccine 
distribution.1–4 Gavi, the Vaccine Alliance—an organisation 
created in 2000—has been an important facilitator of 
improved access to more vaccines among children in 
poor countries.
Immunisation programmes have made strides in 
reaching populations at large.5 For example, in 2014, 
delivery of three doses of the combined diphtheria, 
tetanus toxoid, and pertussis-containing vaccine (DTP3) 
reached 86% worldwide.6 However, with about 
18·7 million infants unvaccinated or undervaccinated,6 
there is a growing need to ensure that disadvantaged 
populations are not left behind. Not only are poorer 
children more susceptible to infectious disease but also 
the tendency for geographical clustering of disadvantaged 
subgroups might result in an absence of herd immunity.7 
In multicountry analyses, inequalities in child immun-
isation indicators have been reported, noting that richer 
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subgroups within countries tend to have high coverage 
whereas the coverage level among poorer subgroups is 
variable across countries.8,9 In some cases, disadvantaged 
populations have been reached successfully through 
equity-oriented immunisation programmes;10,11 however, 
without an explicit focus on equity, disadvantaged 
populations generally report lower immunisation 
coverage,7,12 sometimes even alongside improving 
national ﬁ gures.13,14
An equity-oriented approach to increasing the reach of 
immunisation programmes should consider inequalities 
between countries and within countries and tailor 
programmes accordingly. The Global Vaccine Action Plan 
(GVAP)—endorsed by the 194 Member States of the 
World Health Assembly in 2012—promotes equitable 
access to vaccines for all people by the year 2020.2 GVAP 
speciﬁ es indicators that address within-country inequality, 
including a measure that compares the level of DTP3 
coverage in the country’s poorest wealth quintile with the 
level in the richest wealth quintile.2 National-level 
information has been used to identify priority countries 
and direct resource allocation (eg, through the work of 
Gavi, the Vaccine Alliance). High-priority countries—
identiﬁ ed based on low national immunisation coverage 
and the absolute number of children who are 
unvaccinated—include DR Congo, Ethiopia, Indonesia, 
Nigeria, Pakistan, and Uganda.
The Sustainable Development Goals (SDGs) seek to 
reduce inequalities (goal 10) and ensure health and 
wellbeing for all (goal 3).1 Achieving universal coverage of 
immunisation programmes constitutes an important 
contribution to these goals and to the promotion of child 
survival and health at large. Measuring inequalities in 
DTP3 immunisation coverage between countries and 
within countries reveals where gaps exist in a routinely 
delivered vaccine and helps to inform appropriate 
approaches to reach at-risk populations. Assessing the 
extent to which gains in national coverage are driven by 
Research in context
Evidence before this study
We searched PubMed on July 22, 2015, to identify publications 
in English only addressing inequalities in immunisation 
coverage, with the search terms “healthcare disparities”[Mesh] 
AND “immunization”[Mesh]. Our search yielded 97 results, 
dating back to 2007 (no ﬁ lters were applied). We reviewed the 
titles and abstracts of these papers and selected ten relevant 
peer-reviewed publications for full-text review. We applied a 
snowball searching technique, drawing on the citations within 
these reports and other suggested similar papers, to identify 
further relevant studies. We also identiﬁ ed major global 
initiatives that promote immunisation and reviewed related 
documentation for the inclusion of equity-related 
considerations or reporting. These initiatives comprised: the 
Global Vaccine Action Plan; the Millennium Development Goals; 
the Decade of Vaccines; Global Immunization Vision and 
Strategy; and the Sustainable Development Goals. In the same 
manner, we reviewed publications of global organisations that 
report data about immunisation coverage in low-income and 
middle-income countries, including: WHO; Gavi, the Vaccine 
Alliance; UNICEF; the World Bank; Countdown to 2015; and Save 
the Children. We consulted with experts in the area of health 
inequality monitoring to identify other key academic or grey 
literature. The Global Vaccine Action Plan—endorsed by the 
194 Member States of the World Health Assembly in 2012 and 
supported through the work of Gavi, the Vaccine Alliance and 
other organisations—promotes equitable access to vaccines for 
all people by the year 2020. The Plan highlights the need to 
promote within-country equity and requests the monitoring of 
coverage gaps between wealth quintiles (and other appropriate 
indicators). Speciﬁ cally, strategic objective three in the Global 
Vaccine Action Plan seeks to ensure that the beneﬁ ts of 
immunisation are extended equitably to all, with a call to build a 
knowledge base and capacity for enabling equitable delivery.
Added value of this study
We used the latest available household survey data gathered in 
51 low-income and middle-income countries to provide an 
update about the global state of inequality in DTP3 
immunisation coverage. Use of disaggregated data from 
Demographic and Health Surveys (DHS) and Multiple Indicator 
Cluster Surveys (MICS) enabled comparisons across countries 
and within countries over time. We presented the level of DTP3 
immunisation coverage by wealth quintile in every country, 
thus extending conventional reporting of between-country 
inequality (ie, comparisons of national averages). Furthermore, 
we used data from two timepoints to quantify and compare 
how within-country inequality has changed over time (previous 
10 years). Although many study countries had a narrowing of 
inequality over the past 10 years, substantial inequality persists 
within most study countries. We also noted variability in the 
state of inequality across study countries.
Implications of all the available evidence
The Sustainable Development Goals seek to reduce inequalities 
and ensure health and wellbeing for all, including a movement 
towards universal health coverage. In general, monitoring 
within-country inequalities in any health topic is important to 
ensure that the status of disadvantaged populations is not 
masked behind national averages; health inequality monitoring 
is fundamental to promoting the progressive realisation of 
universal health coverage. Knowledge about health inequalities 
helps to inform approaches to reach at-risk populations. 
Where warranted, inequalities should be addressed on a priority 
basis through equity-oriented and context-appropriate policies, 
programmes, and practices. Future studies can build on our 
results to further investigate underlying determinants of 
inequalities within countries.
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gains among poorer population subgroups is important 
for understanding whether within-country inequalities 
are reducing or widening. The objective of our study is to 
provide a detailed update about the state of between-
country inequality and within-country economic-related 
inequality in childhood DTP3 immunisation in low-
income and middle-income countries, with particular 
focus on inequalities in high-priority countries.
Methods
Data source
The disaggregated data, which are available through 
WHO Health Equity Monitor, are the product of reanalyses 
of publicly available microdata from the Demographic and 
Health Survey (DHS) and the Multiple Indicator Cluster 
Survey (MICS). DHS and MICS are large-scale, nationally 
representative household health surveys conducted 
through standardised face-to-face interviews with women 
aged 15–49 years.15 We assumed the design and 
implementation quality of both DHS and MICS were 
suﬃ  ciently similar to permit direct comparisons between 
surveys, both across countries and over time.8,16,17
We deﬁ ned DTP3 immunisation coverage as the 
percentage of children aged 12–23 months who had 
received three doses of DTP3-containing vaccine at the 
time of the DHS or MICS. In some countries, indicator 
data reﬂ ect an alternative vaccination schedule of 
15–26 months or 18–29 months, which is related to the 
child’s age when the measles vaccine is oﬀ ered.
We ascertained economic status based on a household 
wealth index,18 which accounts for ownership of speciﬁ c 
household items and access to speciﬁ c services. 
We constructed country-speciﬁ c indices by principal 
component analysis, generating quintiles ranging from 
quintile 1 (poorest) to quintile 5 (richest).
Country selection
We selected countries for inclusion based on data 
availability and survey year (reﬂ ecting the initial year of 
data collection, if spanning multiple calendar years). We 
used data from the latest available DHS or MICS 
(conducted between 2010 and 2013) for analysis of latest 
status. To analyse change over time, we obtained data 
from surveys done about 10 years previously (between 
2000 and 2003). From available survey data, we deemed 
countries with the highest number of unvaccinated 
children and/or lowest coverage estimates to be 
high-priority countries for further analysis. All available 
survey data (from at least two household surveys) were 
reported for high-priority countries.
Statistical analysis
Data for DTP3 coverage were disaggregated by wealth 
quintile. We calculated diﬀ erence and ratio measures in 
each of the study countries to show the latest status of 
inequality, based on the level of coverage in quintiles 1 
and 5. Diﬀ erence is an expression of absolute inequality 
(quintile 5–quintile 1) whereas ratio expresses relative 
inequality (quintile 5/quintile 1).
We applied a measure of excess change to the countries 
with data from a previous DHS or MICS, expressing 
change in economic-related inequality over time. We 
calculated excess change as an annual absolute value, 
based on comparison of the pace of change in quintiles 1 
and 5. First, for each quintile 1 and 5, we calculated the 
annual absolute pace of change as the diﬀ erence between 
coverage in the latest survey and coverage in the survey 
done about 10 years earlier, divided by the number of 
years between the two surveys. Then, we subtracted 
the annual absolute pace of change in quintile 5 from the 
annual absolute pace of change in quintile 1, yielding 
annual excess change in percentage points. A positive 
excess change value reﬂ ects a pro-poor change: 
if coverage increased in both quintiles 1 and 5, then the 
growth in coverage occurred faster in quintile 1 than 
quintile 5. A negative excess change value reﬂ ects a 
pro-rich change, whereby the pace of change was more 
favourable in quintile 5. The interpretation of excess 
change values for all possible underlying scenarios has 
been detailed elsewhere.8
We ascertained statistical signiﬁ cance with 95% CIs. 
We took into account the survey sampling design for 
calculating point estimates of disaggregated data and 
their 95% CIs. We used Taylor series method to calculate 
SEs of the summary measures of inequality.
Role of the funding source
The funder had no role in study design, data collection, 
data analysis, data interpretation, or writing of the report. 
The corresponding author had full access to all the data 
in the study and had ﬁ nal responsibility for the decision 
to submit for publication.
Results
Data for 51 low-income and middle-income countries 
were included in latest status analyses (appendix). Of 
these, 21 countries had data available from surveys done 
about 10 years previously, and these countries were 
included in analyses of change over time. Moreover, 
six high-priority countries were identiﬁ ed for further 
analysis: DR Congo, Ethiopia, Indonesia, Nigeria, 
Pakistan, and Uganda.
DTP3 immunisation coverage varied widely between 
and within the 51 countries (table 1). National coverage 
ranged from as low as 32% in Central African Republic 
to nearly universal coverage in Jordan (98%). A third of 
countries had national DTP3 coverage of 90% or higher. 
However, in Central African Republic, Ethiopia, Guinea, 
and Nigeria, at least half the child population was not 
covered by DTP3 immunisation.
Overall, DTP3 immunisation coverage tended to be 
lowest in children from poorer households, and 
increased with rising economic status, indicating pro-
rich inequality. Median DTP3 coverage was 74% among 
See Online for appendix
For more on DHS see 
http://dhsprogram.com
For more on Health Equity 
Monitor see http://www.who.
int/gho/health_equity/en
For more on MICS see 
http://mics.unicef.org
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 National average 
(95% CI)
Quintile 1 (95% CI) Quintile 2 (95% CI) Quintile 3 (95% CI) Quintile 4 (95% CI) Quintile 5 (95% CI) Diﬀ erence 
(percentage points; 
95% CI)*
Ratio (95% CI)†
Armenia 95·0% (90·4–97·4) 88·3% (68·0–96·4) 99·1% (93·4–99·9) 94·2% (81·3–98·4) 96·1% (86·0–99·0) 96·9% (89·3–99·2) 8·6 (–5·0 to 22·3) 1·10 (0·94–1·28)
Bangladesh 93·4% (91·5–95·0) 90·3% (85·9–93·5) 90·1% (84·9–93·6) 93·2% (89·3–95·8) 96·3% (93·1–98·0) 97·8% (94·9–99·1) 7·5 (3·3 to 11·7) 1·08 (1·03–1·13)
Belize 71·4% (66·5–75·8) 71·7% (62·4–79·5) 71·3% (61·2–79·7) 70·3% (56·7–81·0) 75·0% (61·5–85·0) 68·9% (56·1–79·3) –2·8 (–17·4 to 11·7) 0·96 (0·78–1·18)
Benin 73·9% (71·4–76·3) 59·0% (53·4–64·5) 67·9% (63·0–72·4) 76·5% (72·1–80·5) 80·2% (76·0–83·8) 85·6% (80·4–89·7) 26·6 (19·4 to 33·8) 1·45 (1·30–1·62)
Bosnia and 
Herzegovina
92·2% (89·4–94·3) 91·4% (84·0–95·6) 90·4% (82·7–94·9) 91·7% (83·7–96·0) 93·4% (86·2–96·9) 93·8% (87·1–97·1) 2·3 (–4·9 to 9·6) 1·03 (0·95–1·11)
Burkina Faso 89·5% (87·6–91·2) 83·4% (78·7–87·2) 87·9% (84·1–90·8) 91·6% (88·9–93·7) 92·5% (89·5–94·7) 92·9% (87·8–95·9) 9·5 (3·7 to 15·2) 1·11 (1·04–1·19)
Burundi 95·7% (94·3–96·8) 94·4% (90·9–96·6) 96·1% (92·7–98·0) 96·9% (92·0–98·8) 96·9% (93·9–98·5) 94·2% (90·8–96·4) –0·2 (–4·1 to 3·7) 1·00 (0·96–1·04)
Cambodia 84·8% (82·3–87·0) 73·5% (67·8–78·4) 82·9% (77·2–87·4) 88·6% (83·8–92·1) 90·7% (85·6–94·2) 92·6% (88·4–95·3) 19·1 (12·8 to 25·4) 1·26 (1·16–1·37)
Cameroon 68·8% (65·2–72·2) 44·6% (37·3–52·1) 66·3% (59·4–72·7) 74·0% (68·0–79·3) 77·9% (73·1–82·0) 87·6% (83·5–90·8) 43·0 (34·7 to 51·2) 1·96 (1·65–2·33)
Central 
African 
Republic
32·1% (28·5–36·0) 17·8% (13·9–22·6) 21·0% (17·0–25·7) 28·0% (23·4–33·0) 45·2% (38·6–52·0) 59·6% (50·9–67·7) 41·7 (32·2 to 51·3) 3·34 (2·52–4·43)
Colombia 90·5% (89·2–91·7) 84·9% (81·8–87·6) 92·0% (89·3–94·1) 93·4% (90·7–95·3) 91·8% (88·1–94·5) 92·5% (87·6–95·5) 7·6 (2·8 to 12·3) 1·09 (1·03–1·15)
Comoros 73·1% (67·9–77·7) 57·5% (46·8–67·6) 66·3% (55·5–75·6) 80·5% (72·2–86·8) 82·5% (71·4–89·9) 83·5% (72·8–90·5) 26·0 (12·3 to 39·7) 1·45 (1·18–1·79)
Congo 69·1% (64·9–73·1) 54·6% (49·7–59·4) 61·9% (52·4–70·7) 73·4% (64·6–80·7) 81·1% (72·5–87·4) 81·6% (72·9–88·0) 27·0 (18·1 to 36·0) 1·50 (1·32–1·70)
Costa Rica 94·2% (88·1–97·3) 89·3% (69·2–96·9) 97·0% (90·2–99·1) 95·2% (80·4–99·0) 95·5% (77·7–99·2) 97·2% (86·9–99·4) 7·8 (–5·5 to 21·1) 1·09 (0·94–1·26)
Côte d’Ivoire 63·8% (59·4–68·0) 52·1% (44·3–59·8) 60·4% (53·1–67·3) 58·1% (49·7–66·1) 73·9% (66·2–80·4) 80·7% (72·4–86·9) 28·6 (17·9 to 39·2) 1·55 (1·30–1·84)
DR Congo 60·6% (56·9–64·2) 48·1% (42·1–54·2) 51·0% (45·4–56·6) 56·5% (50·5–62·3) 69·8% (63·6–75·4) 83·0% (77·2–87·5) 34·9 (26·9 to 42·8) 1·72 (1·50–1·98)
Ethiopia 37·0% (33·0–41·3) 26·0% (20·0–33·2) 29·4% (23·0–36·7) 31·4% (24·1–39·8) 42·8% (35·2–50·8) 63·6% (54·5–71·8) 37·5 (26·6 to 48·5) 2·44 (1·83–3·26)
Gabon 72·9% (68·5–76·8) 62·2% (55·6–68·3) 78·1% (70·8–84·0) 67·7% (57·1–76·7) 88·1% (78·7–93·6) 71·8% (55·1–84·1) 9·7 (–6·4 to 25·7) 1·16 (0·92–1·45)
Ghana 92·9% (90·8–94·6) 93·0% (88·5–95·8) 93·2% (88·6–96·0) 90·1% (83·7–94·2) 94·0% (87·3–97·3) 94·4% (87·0–97·7) 1·4 (–4·6 to 7·5) 1·02 (0·95–1·08)
Guinea 50·0% (45·5–54·5) 32·4% (26·1–39·3) 53·2% (43·4–62·8) 51·6% (43·6–59·6) 54·5% (47·0–61·8) 63·0% (54·0–71·3) 30·7 (19·7 to 41·6) 1·95 (1·52–2·49)
Haiti 62·8% (58·8–66·6) 54·7% (45·5–63·6) 63·3% (55·5–70·4) 67·0% (59·8–73·4) 62·9% (54·7–70·5) 67·9% (57·3–77·0) 13·2 (–0·2 to 26·7) 1·24 (1·00–1·55)
Honduras 95·6% (94·4–96·6) 96·4% (94·3–97·7) 94·9% (91·7–96·9) 93·7% (90·3–95·9) 95·7% (91·9–97·7) 98·1% (94·8–99·3) 1·7 (–0·9 to 4·3) 1·02 (0·99–1·04)
Indonesia 72·2% (69·8–74·5) 52·5% (47·8–57·2) 69·1% (64·1–73·7) 75·0% (70·0–79·3) 81·0% (76·1–85·2) 85·1% (80·8–88·6) 32·6 (26·5 to 38·7) 1·62 (1·47–1·79)
Iraq 70·1% (68·3–71·9) 55·2% (51·7–58·6) 67·8% (64·3–71·1) 72·6% (68·9–76·0) 79·6% (76·1–82·8) 82·3% (77·6–86·1) 27·1 (21·6 to 32·6) 1·49 (1·38–1·62)
Jordan 98·4% (97·6–99·0) 96·2% (93·3–97·9) 99·1% (98·1–99·6) 99·2% (97·9–99·7) 99·3% (98·3–99·7) 99·1% (94·4–99·9) 2·8 (0·1 to 5·6) 1·03 (1·00–1·06)
Kazakhstan 96·8% (95·1–97·9) 97·1% (93·3–98·8) 98·9% (95·6–99·7) 97·0% (92·7–98·8) 94·4% (89·2–97·2) 95·2% (90·3–97·7) –2·0 (–6·2 to 2·3) 0·98 (0·94–1·02)
Kyrgyzstan 87·4% (84·0–90·2) 94·3% (89·3–97·0) 95·4% (90·1–97·9) 90·8% (84·2–94·8) 82·1% (74·5–87·8) 75·0% (64·9–83·0) –19·3 (–29·1 to –9·5) 0·80 (0·70–0·90)
Laos 55·5% (52·1–58·8) 36·8% (31·3–42·6) 46·6% (40·7–52·6) 59·4% (53·7–64·9) 67·6% (61·2–73·4) 81·4% (75·2–86·3) 44·6 (36·7 to 52·6) 2·21 (1·87–2·62)
Liberia 71·5% (67·4–75·3) 58·0% (51·2–64·5) 72·1% (66·1–77·3) 73·6% (65·1–80·6) 78·3% (68·6–85·6) 79·4% (69·3–86·8) 21·4 (10·4 to 32·4) 1·37 (1·17–1·60)
Macedonia 95·2% (90·7–97·5) 92·7% (79·1–97·7) 98·9% (92·7–99·8) 96·2% (86·2–99·1) 93·7% (73·2–98·8) 94·0% (78·8–98·5) 1·2 (–10·3 to 12·7) 1·01 (0·90–1·15)
Malawi 93·2% (91·8–94·4) 91·4% (88·7–93·6) 93·7% (91·4–95·4) 92·2% (88·4–94·8) 94·8% (92·0–96·7) 94·3% (90·9–96·5) 2·9 (–0·7 to 6·5) 1·03 (0·99–1·07)
Mali 63·7% (60·3–66·9) 48·6% (41·0–56·2) 58·4% (52·4–64·2) 61·4% (55·2–67·3) 72·6% (67·4–77·3) 77·6% (72·6–81·8) 29·0 (20·1 to 37·9) 1·60 (1·35–1·89)
Mongolia 92·7% (90·4–94·5) 91·2% (86·9–94·1) 92·5% (87·5–95·6) 92·7% (86·6–96·1) 91·6% (84·1–95·7) 96·1% (90·6–98·5) 4·9 (0·0 to 9·9) 1·05 (1·00–1·11)
Mozambique 76·9% (73·8–79·8) 65·4% (58·2–71·9) 70·8% (65·4–75·6) 81·0% (75·8–85·3) 86·0% (81·5–89·5) 87·5% (83·5–90·7) 22·2 (14·4 to 29·9) 1·34 (1·20–1·50)
Nepal 91·8% (88·5–94·3) 88·1% (81·7–92·5) 89·7% (81·6–94·5) 90·5% (82·4–95·0) 96·7% (91·8–98·8) 98·4% (94·9–99·5) 10·3 (4·7 to 15·9) 1·12 (1·05–1·19)
Niger 68·5% (64·9–71·9) 53·3% (46·7–59·7) 65·0% (57·6–71·7) 68·2% (61·8–74·0) 70·5% (63·0–77·0) 84·4% (80·2–87·8) 31·1 (23·5 to 38·6) 1·58 (1·39–1·80)
Nigeria 38·5% (35·5–41·6) 7·4% (5·6–9·6) 18·9% (15·9–22·3) 40·1% (36·0–44·3) 60·1% (55·5–64·5) 79·6% (76·1–82·7) 72·3 (68·4 to 76·1) 10·82 (8·21–14·25)
Pakistan 65·3% (60·5–69·8) 29·9% (21·6–39·7) 67·5% (60·1–74·2) 69·2% (61·7–75·9) 78·9% (73·5–83·4) 88·0% (83·6–91·3) 58·1 (48·2 to 68·0) 2·95 (2·17–4·01)
Peru 83·7% (81·4–85·8) 83·4% (79·4–86·8) 82·5% (77·9–86·3) 85·1% (79·7–89·2) 80·3% (73·5–85·7) 88·6% (80·2–93·7) 5·1 (–2·4 to 12·6) 1·06 (0·97–1·16)
Philippines 86·2% (84·1–88·1) 78·5% (73·7–82·7) 83·7% (78·9–87·6) 89·1% (84·7–92·3) 91·6% (87·1–94·7) 93·0% (87·8–96·1) 14·5 (8·5 to 20·5) 1·18 (1·10–1·27)
Rwanda 96·9% (95·8–97·8) 96·1% (93·3–97·8) 95·7% (92·7–97·4) 97·1% (94·3–98·5) 97·9% (95·5–99·0) 98·7% (96·8–99·5) 2·6 (0·1 to 5·0) 1·03 (1·00–1·05)
Senegal 88·8% (86·2–90·9) 80·2% (73·3–85·6) 88·0% (83·4–91·4) 93·1% (88·5–95·9) 91·2% (84·3–95·2) 94·6% (87·2–97·8) 14·4 (6·6 to 22·2) 1·18 (1·08–1·29)
Sierra Leone 78·5% (75·4–81·2) 79·4% (74·0–84·0) 77·6% (71·7–82·5) 79·7% (74·7–83·9) 81·6% (76·2–86·0) 72·3% (64·0–79·4) –7·1 (–16·3 to 2·1) 0·91 (0·80–1·03)
Suriname 55·4% (50·0–60·7) 64·0% (56·5–70·9) 50·7% (40·1–61·3) 56·3% (45·4–66·5) 51·0% (38·5–63·4) 45·9% (31·8–60·6) –18·1 (–34·6 to –1·7) 0·72 (0·51–0·99)
Swaziland 90·6% (87·4–93·1) 89·7% (82·2–94·3) 91·7% (82·6–96·2) 94·0% (87·0–97·3) 92·1% (83·6–96·4) 83·6% (73·3–90·4) –6·1 (–16·4 to 4·2) 0·93 (0·83–1·05)
Tajikistan 93·2% (90·8–95·0) 92·9% (84·2–97·0) 95·6% (91·3–97·8) 93·3% (88·7–96·2) 91·9% (85·7–95·6) 91·6% (86·8–94·7) –1·3 (–8·4 to 5·8) 0·99 (0·91–1·06)
Tanzania 88·0% (84·9–90·6) 84·1% (77·4–89·0) 84·1% (77·4–89·0) 87·3% (81·9–91·2) 91·3% (84·4–95·3) 96·9% (93·2–98·6) 12·9 (6·6 to 19·1) 1·15 (1·07–1·24)
(Table 1 continues on next page)
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children in quintile 1 compared with 86% in quintile 5 
(ﬁ gure 1). On the whole, study countries reported a 
wider range of coverage values in quintile 1 than 
quintile 5.
In 20 countries, pro-rich inequality was substantial, 
with a gap in DTP3 immunisation coverage of 
20 percentage points or more between quintiles 1 and 5 
(table 1). In Nigeria, Pakistan, Laos, Cameroon, and 
Central African Republic, the level of absolute inequality 
was very high, with a diﬀ erence exceeding 40 percentage 
points. Several countries (Nigeria, Central African 
Republic, Pakistan, Ethiopia, and Laos) indicated high 
relative inequality, with DTP3 immunisation coverage at 
least twice as high in quintile 5 than in quintile 1. 
Kyrgyzstan and Suriname showed pro-poor inequality 
whereby, in absolute terms, coverage was signiﬁ cantly 
higher in quintile 1 than in quintile 5. In 18 countries, the 
absolute diﬀ erence in DTP3 immunisation coverage 
between richest and poorest quintiles did not reach 
signiﬁ cance.
In 15 of 21 countries, national DTP3 immunisation 
coverage rose signiﬁ cantly over time, and a further 
two countries had growth of borderline signiﬁ cance. In 
Burkina Faso, Cambodia, Gabon, Uganda, Mali, and 
Nepal, the absolute increase in coverage was at least 
2·0 percentage points per year (table 2). In most 
countries, an escalation in national coverage was 
achieved alongside faster improvement in quintile 1 
compared with quintile 5 (ﬁ gure 2). Pro-poor excess 
change was signiﬁ cant in 11 countries. In Mozambique, 
Ghana, Burkina Faso, and Gabon, the DTP3 coverage 
increase in the poorest quintile outpaced that in the 
richest quintile by at least 2·0 percentage points per year 
(table 2). Nigeria was the only study country with a 
signiﬁ cant pro-rich excess change, with the improvement 
in quintile 5 exceeding that in quintile 1.
Substantial economic-related inequality in DTP3 
immunisation coverage was noted in all high-priority 
countries, except Uganda (ﬁ gure 3). In DR Congo, an 
increase in coverage between DHS 2007 and DHS 2013 
was seen in all quintiles, with remarkable growth in 
poorer quintiles. Although inequality narrowed in DHS 
2013, the gap in coverage was still large (about 
35 percentage points). In Ethiopia, economic-related 
inequality persisted between DHS 2000 and DHS 2011, 
despite overall gains in DTP3 coverage in all quintiles. 
In DHS 2005, large improvements were noted in poorer 
quintiles alongside some improvement in richer 
quintiles, whereas substantial gains in richer quintiles 
were evident in DHS 2011, and poorer quintiles showed 
no improvement. In Indonesia, DHS 2012 indicated a 
signiﬁ cant pro-rich absolute diﬀ erence in DTP3 
immunisation coverage (32·6 percentage points, 95% CI 
26·5–38·7). Although national coverage grew over the 
period 2002–12, improvements were achieved at a similar 
pace in quintiles 1 and 5 and, thus, the gap between these 
quintiles persisted. Faster improvements, however, were 
 National average 
(95% CI)
Quintile 1 (95% CI) Quintile 2 (95% CI) Quintile 3 (95% CI) Quintile 4 (95% CI) Quintile 5 (95% CI) Diﬀ erence 
(percentage points; 
95% CI)*
Ratio (95% CI)†
(Continued from previous page)
Togo 72·4% (68·4–76·0) 62·8% (54·9–70·1) 75·2% (67·8–81·3) 70·6% (61·6–78·2) 73·8% (64·3–81·5) 84·4% (74·8–90·8) 21·6 (10·6 to 32·6) 1·34 (1·15–1·57)
Uganda 72·2% (68·8–75·4) 74·5% (67·6–80·4) 72·6% (65·7–78·5) 67·2% (60·2–73·4) 71·3% (62·9–78·5) 74·8% (67·1–81·3) 0·3 (–9·3 to 9·9) 1·00 (0·88–1·14)
Vietnam 73·9% (69·8–77·7) 59·3% (49·3–68·6) 71·7% (61·1–80·3) 74·1% (64·2–82·1) 78·1% (68·8–85·1) 85·5% (78·1–90·8) 26·2 (14·6 to 37·9) 1·44 (1·20–1·73)
Zimbabwe 73·6% (69·3–77·4) 67·4% (59·1–74·7) 71·2% (62·5–78·6) 71·2% (62·9–78·4) 78·8% (72·0–84·3) 80·9% (73·5–86·7) 13·5 (3·3 to 23·8) 1·20 (1·04–1·38)
Median 76·9% 73·5% 77·6% 80·5% 82·1% 85·6% 12·9 1·16
Data taken from DHS and MICS 2010–13. DHS=Demographic and Health Survey. DTP3=three doses of the combined diphtheria, tetanus toxoid, and pertussis vaccine. MICS=Multiple Indicator Cluster Survey. 
*Calculated by subtracting the level of coverage in quintile 1 from the level of coverage in quintile 5. †Calculated by dividing the level of coverage in quintile 5 by the level of coverage in quintile 1.
Table 1: Latest situation in DTP3 immunisation coverage among children aged 12–23 months in 51 low-income and middle-income countries
Figure 1: Latest situation of DTP3 coverage among children aged 12–23 months 
in 51 low-income and middle-income countries, by economic status
Data taken from DHS and MICS 2010–13. Box and whisker plots show the 
distribution of DTP3 coverage within wealth quintiles of 51 low-income and 
middle-income countries. Whiskers represent maximum and minimum values; 
the centre line denotes the median value; and the shaded box indicates the IQR 
(middle 50% of country estimates). DHS=Demographic and Health Survey. 
DTP3=three doses of the combined diphtheria, tetanus toxoid, and pertussis 
vaccine. MICS=Multiple Indicator Cluster Survey.
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noted in intermediate quintiles (notably, quintile 2). In 
Nigeria, DHS 2003 showed a large gap in coverage 
between quintile 5 and all other quintiles—eg, the 
diﬀ erence between quintiles 5 and 4 was 40 percentage 
points, and the diﬀ erence between quintiles 5 and 1 was 
56 percentage points. DHS 2008 and DHS 2013 indicated 
faster improvements in quintiles 3, 4, and 5 than in 
quintiles 1 and 2; as a result, inequality between quintiles 
5 and 4 halved (to 20 percentage points in DHS 2013), 
but inequality between quintiles 5 and 1 increased 
National average Quintile 1 Quintile 5 Absolute annual 
excess change 
(percentage 
points) (95% CI)†
Coverage in 
year 1 
(95% CI)
Coverage in 
year 2 
(95% CI)
Absolute annual 
change 
(percentage 
points) (95% CI)*
Coverage in 
year 1 
(95% CI)
Coverage in 
year 2 
(95% CI)
Absolute annual 
change 
(percentage 
points) (95% CI)*
Coverage in 
year 1 
(95% CI)
Coverage in 
year 2 
(95% CI)
Absolute annual 
change 
(percentage 
points) (95% CI)*
Armenia 89·7% 
(85·4 to 92·8)
95·0% 
(90·4 to 97·4)
0·5
(0·0 to 1·0)
89·3% 
(80·9 to 94·2)
88·3% 
(68·0 to 96·4)
–0·1
(–1·6 to 1·4)
83·5% 
(69·6 to 91·8)
96·9% 
(89·3 to 99·2)
1·3
(0·2 to 2·5)
–1·4
(–3·3 to 0·4)
Benin 72·9% 
(69·0 to 76·5)
73·9% 
(71·4 to 76·3)
0·1
(–0·3 to 0·6)
63·5% 
(55·7 to 70·6)
59·0% 
(53·4 to 64·5)
–0·4
(–1·4 to 0·5)
89·5% 
(82·4 to 93·9)
85·6% 
(80·4 to 89·7)
–0·4
(–1·1 to 0·3)
–0·1
(–1·2 to 1·1)
Burkina Faso 57·1% 
(52·3 to 61·7)
89·5% 
(87·6 to 91·2)
4·6
(3·9 to 5·4)
45·7% 
(38·6 to 53·0)
83·4% 
(78·7 to 87·2)
5·4
(4·2 to 6·6)
72·5% 
(65·7 to 78·4)
92·9% 
(87·8 to 95·9)
2·9
(1·8 to 4·0)
2·5
(0·9 to 4·1)
Cambodia 48·8% 
(44·8 to 52·8)
84·8% 
(82·3 to 87·0)
3·6
(3·1 to 4·1)
39·0% 
(32·5 to 45·8)
73·5% 
(67·8 to 78·4)
3·4
(2·6 to 4·3)
74·7% 
(65·3 to 82·3)
92·6% 
(88·4 to 95·3)
1·8
(0·9 to 2·7)
1·7
(0·4 to 2·9)
Colombia 77·2% 
(73·8 to 80·2)
90·5% 
(89·2 to 91·7)
1·3
(1·0 to 1·7)
64·2% 
(56·9 to 70·8)
84·9% 
(81·8 to 87·6)
2·1
(1·3 to 2·8)
86·0% 
(79·0 to 90·9)
92·5% 
(87·6 to 95·5)
0·7
(0·0 to 1·4)
1·4
(0·4 to 2·5)
Ethiopia 21·1% 
(18·2 to 24·5)
37·0% 
(33·0 to 41·3)
1·4
(1·0 to 1·9)
15·3% 
(11·4 to 20·2)
26·0% 
(20·0 to 33·2)
1·0
(0·3 to 1·7)
43·1% 
(33·5 to 53·1)
63·6% 
(54·5 to 71·8)
1·9
(0·7 to 3·1)
–0·9
(–2·3 to 0·5)
Gabon 37·7% 
(33·6 to 42·0)
72·9% 
(68·5 to 76·8)
2·9
(2·4 to 3·4)
18·9% 
(14·5 to 24·4)
62·2% 
(55·6 to 68·3)
3·6
(2·9 to 4·3)
53·2% 
(42·1 to 64·1)
71·8% 
(55·1 to 84·1)
1·6
(0·0 to 3·1)
2·1 
(0·4 to 3·7)
Ghana 79·8% 
(76·0 to 83·1)
92·9% 
(90·8 to 94·6)
1·6
(1·1 to 2·1)
65·7% 
(56·6 to 73·7)
93·0% 
(88·5 to 95·8)
3·4
(2·2 to 4·6)
87·4% 
(78·9 to 92·8)
94·4% 
(87·0 to 97·7)
0·9
(–0·2 to 1·9)
2·5
(1·0 to 4·1)
Haiti 42·9% 
(36·9 to 49·1)
62·8% 
(58·8 to 66·6)
1·7
(1·1 to 2·3)
31·1% 
(23·5 to 39·8)
54·7% 
(45·5 to 63·6)
2·0
(0·9 to 3·0)
57·6% 
(35·1 to 77·3)
67·9% 
(57·3 to 77·0)
0·9
(–1·2 to 2·9)
1·1
(–1·2 to 3·4)
Indonesia 58·6% 
(55·0 to 62·1)
72·2% 
(69·8 to 74·5)
1·4
(0·9 to 1·8)
41·9% 
(35·9 to 48·1)
52·5% 
(47·8 to 57·2)
1·1
(0·3 to 1·8)
72·3% 
(64·1 to 79·2)
85·1% 
(80·8 to 88·6)
1·3 
(0·4 to 2·1)
–0·2
(–1·4 to 0·9)
Jordan 98·3% 
(97·2 to 98·9)
98·4% 
(97·6 to 99·0)
0·0
(–0·1 to 0·1)
98·3% 
(96·7 to 99·2)
96·2% 
(93·3 to 97·9)
–0·2
(–0·5 to 0·0)
99·5% 
(96·7 to 99·9)
99·1% 
(94·4 to 99·9)
0·0
(–0·2 to 0·1)
–0·2
(–0·5 to 0·1)
Malawi 84·3% 
(81·9 to 86·5)
93·2% 
(91·8 to 94·4)
0·9
(0·6 to 1·1)
77·8% 
(72·7 to 82·2)
91·4% 
(88·7 to 93·6)
1·4
(0·8 to 1·9)
90·6% 
(86·7 to 93·5)
94·3% 
(90·9 to 96·5)
0·4
(–0·1 to 0·8)
1·0
(0·3 to 1·7)
Mali 39·9% 
(35·8 to 44·1)
63·7% 
(60·3 to 66·9)
2·2
(1·7 to 2·7)
28·1% 
(22·1 to 34·9)
48·6% 
(41·0 to 56·2)
1·9
(1·0 to 2·8)
70·8% 
(63·7 to 77·0)
77·6% 
(72·6 to 81·8)
0·6
(–0·1 to 1·4)
1·3
(0·1 to 2·4)
Mozambique 72·1% 
(68·3 to 75·6)
76·9% 
(73·8 to 79·8)
0·6
(0·0 to 1·2)
52·6% 
(45·7 to 59·4)
65·4% 
(58·2 to 71·9)
1·6
(0·4 to 2·8)
96·0% 
(90·4 to 98·4)
87·5% 
(83·5 to 90·7)
–1·1
(–1·7 to –0·4)
2·7
(1·3 to 4·0)
Nepal 72·1% 
(66·8 to 76·9)
91·8% 
(88·5 to 94·3)
2·0
(1·4 to 2·5)
62·1% 
(53·0 to 70·3)
88·1% 
(81·7 to 92·5)
2·6
(1·6 to 3·6)
85·4% 
(77·4 to 90·9)
98·4% 
(94·9 to 99·5)
1·3
(0·6 to 2·0)
1·3
(0·1 to 2·5)
Nigeria 22·2% 
(17·8 to 27·3)
38·5% 
(35·5 to 41·6)
1·6
(1·1 to 2·2)
7·1% 
(4·0 to 12·1)
7·4% 
(5·6 to 9·6)
0·0
(–0·4 to 0·5)
63·0% 
(52·8 to 72·2)
79·6% 
(76·1 to 82·7)
1·7
(0·6 to 2·7)
–1·6
(–2·8 to –0·5)
Peru 84·8% 
(82·9 to 86·5)
83·7% 
(81·4 to 85·8)
–0·1
(–0·3 to 0·1)
76·4% 
(72·4 to 79·9)
83·4% 
(79·4 to 86·8)
0·6
(0·2 to 1·0)
93·0% 
(87·6 to 96·1)
88·6% 
(80·2 to 93·7)
–0·4
(–1·0 to 0·3)
1·0
(0·2 to 1·7)
Philippines 79·0% 
(76·5 to 81·4)
86·2% 
(84·1 to 88·1)
0·7
(0·4 to 1·0)
64·3% 
(58·8 to 69·4)
78·5% 
(73·7 to 82·7)
1·4
(0·7 to 2·1)
92·0% 
(86·1 to 95·6)
93·0% 
(87·8 to 96·1)
0·1
(–0·5 to 0·7)
1·3
(0·4 to 2·2)
Rwanda 86·2% 
(83·7 to 88·4)
96·9% 
(95·8 to 97·8)
1·1
(0·8 to 1·3)
81·1% 
(74·3 to 86·5)
96·1% 
(93·3 to 97·8)
1·5
(0·9 to 2·1)
89·0% 
(84·3 to 92·4)
98·7% 
(96·8 to 99·5)
1·0
(0·6 to 1·4)
0·5
(–0·2 to 1·3)
Uganda 46·2% 
(42·1 to 50·4)
72·2% 
(68·8 to 75·4)
2·4
(1·9 to 2·8)
47·5% 
(38·3 to 56·9)
74·5% 
(67·6 to 80·4)
2·5
(1·4 to 3·5)
40·9% 
(34·4 to 47·8)
74·8% 
(67·1 to 81·3)
3·1
(2·2 to 4·0)
–0·6
(–2·0 to 0·7)
Vietnam 72·4% 
(66·0 to 77·9)
73·9% 
(69·8 to 77·7)
0·2
(–0·7 to 1·1)
52·8% 
(41·7 to 63·6)
59·3% 
(49·3 to 68·6)
0·8
(–1·0 to 2·7)
93·5% 
(87·0 to 96·9)
85·5% 
(78·1 to 90·8)
–1·0
(–2·0 to 0·0)
1·8
(–0·3 to 3·9)
Median 72·1% 83·7% 1·4 52·8% 74·5% 1·5 85·4% 88·6% 0·9 1·1
Data taken from DHS and MICS 2000–03 and 2010–13. DHS=Demographic and Health Survey. DTP3=three doses of the combined diphtheria, tetanus toxoid, and pertussis vaccine. MICS=Multiple Indicator 
Cluster Survey.*Calculated by subtracting coverage in year 1 from coverage in year 2, and dividing by the number of intervening years. †Calculated by subtracting the annual absolute change in quintile 5 from the 
annual absolute change in quintile 1.
Table 2: Change over time in DTP3 immunisation coverage among children aged 12–23 months in 21 low-income and middle-income countries
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(to 72 percentage points in DHS 2013). The level of 
coverage in quintile 1 remained under 10% at all 
timepoints. In Pakistan, substantial inequality was 
reported in immunisation coverage in DHS 2006, with a 
diﬀ erence of more than 40 percentage points between 
quintiles 1 and 5. In DHS 2012, all but the poorest 
quintile had improved coverage, with a notable increase 
of 20 percentage points in quintile 2. Coverage in quintile 
1 decreased, resulting in a widening gap between quintile 
1 and the rest of the population; the coverage gap between 
quintiles 1 and 2 grew by three times between DHS 2006 
(12·6 percentage points) and DHS 2012 (37·6 percentage 
points). Finally, in Uganda, economic-related inequality 
presented an uncommon pattern; the richest 40% 
(quintiles 4 and 5) had the lowest DTP3 coverage in 2000, 
and the poorest (quintile 1) had intermediate coverage. 
The overall situation improved over time, although we 
still do not see the usual increasing pattern of coverage 
from poorest to richest. In any case, wealth-related 
inequality in Uganda has decreased over time. In DHS 
2011, DTP3 coverage was around 75% in both quintile 1 
and quintile 5.
Figure 2: Change over time in national average of DTP3 coverage among children aged 12–23 months, and in quintile 1 compared with quintile 5, 
in 21 low-income and middle-income countries
Data taken from DHS and MICS 2000–03 and 2010–13. Every country is represented by a shape, which corresponds to its WHO region. For every study country, the 
annual absolute change in national average was calculated by subtracting the national coverage in survey year 1 (2000–03) from coverage in survey year 2 (2010–13) 
and dividing by the number of intervening years. The annual absolute excess change was calculated by subtracting the annual absolute change in quintile 5 from the 
annual absolute change in quintile 1. Red and blue boxes portray undesirable and desirable scenarios, respectively. DHS=Demographic and Health Survey. 
DTP3=three doses of the combined diphtheria, tetanus toxoid, and pertussis vaccine. MICS=Multiple Indicator Cluster Survey.
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Figure 3: Change over time in DTP3 coverage among children aged 12–23 months in six high-priority 
countries, by economic status
Data taken from DHS 2000–13. For each country, disaggregated data are presented for wealth quintiles 
by coloured dots; the horizontal lines indicate the diﬀ erence between the most extreme quintile values. 
DHS=Demographic and Health Survey. DTP3=three doses of the combined diphtheria, tetanus toxoid, 
and pertussis vaccine.
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Discussion
In our study of household health surveys, inequality in 
DTP3 immunisation coverage was noted both between 
and within countries. The extent of within-country 
inequality varied by country: most countries (but not all) 
showed substantial pro-rich inequality. In most countries, 
improved national coverage over the past 10 years was 
driven by accelerated improvements in poorer quintiles. 
The criterion of the GVAP indicator relates to within-
country inequality—ie, that DTP3 coverage in quintile 1 
is not more than 20 percentage points below coverage in 
quintile 5. This indicator was not met by 20 of 51 study 
countries. Moreover, ﬁ ve of six high-priority countries 
had a DTP3 immunisation coverage gap of greater than 
20 percentage points between the poorest and richest 
quintiles.
Disaggregating data by wealth quintile allows for closer 
examination of underlying shapes of within-country 
inequality, which helps to indicate equity-oriented 
approaches to expand coverage.19 For instance, a marginal 
exclusion pattern, as seen in Pakistan, generally shows a 
need for interventions targeted to the most disadvantaged 
subgroup (ﬁ gure 4). The mass deprivation pattern in 
Ethiopia suggests a need for a population-wide approach 
that improves coverage in all subgroups. The queuing 
pattern, as reported in Nigeria, prompts an approach that 
combines population-wide and targeted interventions.
Analyses of change over time showed diﬀ erent patterns 
of national improvement in DTP3 immunisation 
coverage across countries. The SDGs call for movement 
towards universal coverage of health services,1 which 
should be realised in an equity-oriented manner: overall 
gains accompanied by accelerated improvements in 
disadvantaged populations.20 Programmes that promote 
expansion of health services should have an equity focus. 
Use of disaggregated data to track changes over time can 
show whether a country is achieving progressive 
realisation of universal coverage.21 Ghana and Nigeria, 
for instance, both reported national absolute annual 
change of 1 · 6 percentage points. Although Ghana 
reported a reduction of inequality (faster improvement in 
the poorest quintile than the richest), Nigeria reported a 
widening of inequality (faster improvement in the richest 
quintile than the poorest). Thus, in the case of 
DTP3 immunisation, data from Ghana indicated an 
equity-oriented progression towards universal coverage.
DTP3 coverage is an appropriate indicator to show a 
country’s capacity to identify and deliver three doses of 
vaccine to the same child at appropriate times through 
routine systems.5 When successful, routine immunisation 
programmes oﬀ er a sustainable approach to delivering 
vaccines, because long-term delivery of vaccines can be 
integrated into the regular activities of national health 
systems.22 By contrast with routine programmes, 
immunisation campaigns can be delivered to provide 
immediate and widespread reach and, in doing so, have 
contributed to making progress towards eradicating some 
diseases or to increase coverage in speciﬁ c acute situations 
(eg, conﬂ icts, natural disasters, or outbreaks). However, 
campaigns are delivered outside of the routine system and 
might lack the resources to ensure sustainability, and 
recognition is growing of the beneﬁ ts of transitioning 
back to routine immunisation. In some situations, 
supplementing routine immunisation with periodic 
intensiﬁ cation and outreach could be appropriate.22
Planning of vaccination campaigns should be informed 
by evidence on the distribution of coverage gaps, with 
dedicated eﬀ orts made to ensure that those people missed 
by routine systems are reached. Following WHO and 
UNICEF recommendations, the Reaching Every District 
(RED) and Reaching Every Community (REC) strategies 
have been implemented successfully in many countries, 
with the objective of addressing common obstacles to 
increase immunisation coverage in areas with low 
coverage. This approach outlines ﬁ ve operational 
components, with one focusing on re-establishment of 
regular outreach services. For outreach activities, 
health-facility staﬀ  leave their facility to deliver vaccine to 
those districts or communities. This approach is 
especially valuable for communities with diﬃ  cult access.23
With the exception of Uganda, the high-priority 
countries highlighted in our study had high levels of 
economic-related inequality in DTP3 immunisation 
coverage, with poorer quintiles lagging behind the rest of 
the population. In general, economic-related inequality is 
typically reﬂ ected in patterns of geographical inequality 
and can be exacerbated in situations of insecurity or 
political instability within countries. Nigeria had 
especially ampliﬁ ed levels of inequality, which could be 
attributable partly to the country’s federal system of 
governance (granting a high degree of autonomy to states 
in the delivery of health care, and resulting in variable 
levels of coverage). A country-tailored approach, based on 
replicating successes of high-performing states, is being 
piloted in Nigeria to address discrepancies between 
Figure 4: Latest situation of DTP3 coverage among children aged 12–23 months 
in three high-priority countries, by economic status
Data taken from DHS 2011–13. DHS=Demographic and Health Survey. 
DTP3=three doses of the combined diphtheria, tetanus toxoid, and pertussis vaccine. 
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states.22 In Ethiopia, challenges in reaching remote areas 
have been addressed by introducing routine outreach 
programmes. In addition to ﬁ xed posts, this approach 
includes outreach services, which are anticipated to better 
reach communities that move seasonally.22 In DR Congo, 
infrastructure development is needed to overcome 
logistical challenges of distributing vaccines throughout 
the country.22 In Pakistan, overall strengthening of health 
systems is needed to deliver vaccines routinely to a 
growing number of children.22 Moving forward, 
assessments of equity-oriented eﬀ orts to improve 
coverage should be done, and successful interventions 
reported and taken to scale.
Strong health information systems are fundamental to 
monitoring inequalities in immunisation coverage and 
across all health topics. Household health surveys such 
as DHS and MICS provide harmonised, disaggregated 
immunisation data that are appropriate for between-
country and within-country inequality monitoring. 
Household health surveys should be done according to a 
regular schedule and be expanded to countries where 
they are not currently done. According to GVAP 
recommendations, household surveys should be 
undertaken at least every 5 years in priority countries. In 
addition to survey data, information from administrative 
activities (eg, immunisation records kept by health 
facilities), censuses, and vital registration systems might 
be useful inputs for inequality monitoring. Whenever 
possible, data sources should contain small area 
identiﬁ ers (eg, postal codes) so that health data can 
be linked with—and disaggregated by—data about 
dimensions of inequality. For example, an analysis of 
inequality in DTP3 coverage in Bogota, Colombia, linked 
district-level data about socioeconomic and living 
conditions (gathered through national surveys) with 
facility data from immunisation registries.24 Future 
research at the country level is warranted to elucidate 
how to strengthen and develop health information 
systems eﬀ ectively within national contexts. In our study 
we used 95% CIs to account for survey sampling error 
and assess statistical signiﬁ cance; however, from a public 
health perspective, signiﬁ cance might not indicate a 
situation that warrants remedial action. For instance, 
Jordan and Rwanda had signiﬁ cant—but, practically, very 
low—levels of absolute inequality (<3 percentage points 
between quintiles 1 and 5).
Pairwise diﬀ erence and ratio inequality measures, 
which compare data in quintiles 1 and 5, do not take into 
account all data and can limit interpretability of results. 
In our study, we chose to present such measures for the 
sake of simplicity. To avoid possible limitations, we did 
compare conclusions arising from these measures with 
more complex inequality measures that take into account 
the full data (slope index of inequality for absolute 
inequality and concentration index for relative inequality) 
to ensure that they were similar. For reference, 
disaggregated data for all quintiles of all study countries 
are available in table 1. Similarly, the excess change 
measure, which expresses change in inequality over 
time, has an inherent limitation because it does not take 
into account changes in quintiles 2, 3, and 4. Figure 3 
shows the change over time across these intermediate 
quintiles in the six high-priority study countries.
To interpret excess change, we must take into account 
the baseline level of coverage. In countries with elevated 
baseline levels of inequality, disadvantaged subgroups 
generally have low levels of coverage and, therefore, 
more room for improvement. In Gabon, for instance, 
less than 19% of children in quintile 1 of the baseline 
survey received vaccines versus 53% of children in 
quintile 5, indicating much room for improvement in 
terms of equity and overall coverage. By contrast, Jordan 
had nearly complete levels of DTP3 coverage across all 
wealth quintiles in both surveys, eﬀ ectively achieving 
near-universal levels of coverage.
The estimates we report are based on disaggregated 
data from household health surveys. This information 
might diﬀ er from reported coverage data from national 
authorities, which are based typically on administrative 
reporting systems or oﬃ  cial WHO and UNICEF 
estimates and are derived through triangulation of survey 
and facility data.
In conclusion, many study countries achieved a 
narrowing of economic-related inequality in DTP3 
coverage over the past 10 years; however, substantial 
inequality persists within most countries and should be 
addressed on a priority basis through equity-oriented 
and context-appropriate policies, programmes, and 
practices. The regular monitoring of within-country 
inequalities in immunisation should have an important 
role in informing eﬀ orts to increase coverage in an 
equity-oriented manner, aiming for those with the 
greatest need to accrue the most substantial gains.
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